ISDA

Entry Detail

PDB ID:

3G8I

Keywords:

TRANSCRIPTION/TRANSFERASE

Title:

Aleglitazar, a new, potent, and balanced PPAR alpha/gamma agonist for the treatment of type II diabetes

Biological Source:

Source Organism:

Homo sapiens,

Host Organism:

Escherichia coli

PDB Version:

Deposition Date:

2009-02-12

Release Date:

2009-06-02

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.20 Å

R-Value Free:

0.26

R-Value Work:

0.19

R-Value Observed:

0.20

Space Group:

P 21 21 21

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Description:Peroxisome proliferator-activated receptor alpha
Chain IDs:A
Chain Length:270
Number of Molecules:1
Biological Source:Homo sapiens

UniProt ID:Q07869 Pfam ID:PF00104

Protein Blast

Polymer Type:polypeptide(L)
Description:Nuclear receptor coactivator 1
Chain IDs:B (auth: Z)
Chain Length:13
Number of Molecules:1
Biological Source:

UniProt ID:Q15788

Ligand Molecules

RO7

Primary Citation

Aleglitazar, a new, potent, and balanced dual PPARalpha/gamma agonist for the treatment of type II diabetes.

Benardeau, A, Benz, J, Binggeli, A, Blum, D, Boehringer, M, Grether, U, Hilpert, H, Kuhn, B, Marki, H.P, Meyer, M, Puntener, K, Raab, S, Ruf, A, Schlatter, D, Mohr, P.Show

Bioorg.Med.Chem.Lett. 19 2468 2473 (2009)

PMID: 19349176 DOI: 10.1016/j.bmcl.2009.03.036

Abstact

Design, synthesis, and SAR of novel alpha-alkoxy-beta-arylpropionic acids as potent and balanced PPARalphagamma coagonists are described. One representative thereof, Aleglitazar ((S)-2Aa), was chosen for clinical development. Its X-ray structure in complex with both receptors as well as its high efficacy in animal models of T2D and dyslipidemia are also presented.

Legend

Protein

Chemical

Disease

Primary Citation of related structures